Transcription profiles of rheumatoid arthritis patients reveal genes characterizing different response to anti-TNF therapy

被引：0
|
作者：
Batliwalla, Franak
Gregersen, Peter
Allaire, Normand
Li, Wentian
Khalili, Houman
Perrin, Steve
Kern, Marlena
Damle, Aarti
Carulli, John
Bienkowska, Jadwiga
机构：
[1] Feinstein Inst Med Res, Manhasset, NY USA
[2] Biogenldec Drug Discovery, Cambridge, NY USA
[3] Biogenldec Drug Discovery, Cambridge, MA USA
来源：
CLINICAL IMMUNOLOGY | 2007年 / 123卷
关键词：
D O I：
10.1016/j.clim.2007.03.373
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [31] Variation at FCGR2A and Functionally Related Genes Is Associated with the Response to Anti-TNF Therapy in Rheumatoid Arthritis
    Avila-Pedretti, Gabriela
    Tornero, Jesus
    Fernandez-Nebro, Antonio
    Blanco, Francisco
    Gonzalez-Alvaro, Isidoro
    Canete, Juan D.
    Maymo, Joan
    Alperiz, Mercedes
    Fernandez-Gutierrez, Benjamin
    Olive, Alex
    Corominas, Hector
    Erra, Alba
    Aterido, Adria
    Lopez Lasanta, Maria
    Tortosa, Rauel
    Julia, Antonio
    Marsal, Sara
    PLOS ONE, 2015, 10 (04):
  • [32] THE IMPACT OF ANTI-TNF ON THE WEIGHT OF RHEUMATOID ARTHRITIS PATIENTS
    Alcorn, Nicola
    Tierney, Ann
    Wu, Olivia
    Gilmour, Harper
    Capell, Hillary
    Madhok, Rajan
    RHEUMATOLOGY, 2009, 48 : I63 - I63
  • [33] Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis
    Coenen, Marieke J. H.
    Toonen, Erik J. M.
    Scheffer, Hans
    Radstake, Timothy R. D. J.
    Barrera, Pilar
    Franke, Barbara
    PHARMACOGENOMICS, 2007, 8 (07) : 761 - 773
  • [34] FRACTURE RISK ASSESSMENT (FRAX) IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THERAPY WITH ANTI-TNFα
    Anghel, D.
    Otlocan, L.
    Negru, M. M.
    Busuioc, E.
    Bursuc, R.
    Smedescu, V.
    Manolache, A.
    Jurcut, C.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S400 - S400
  • [35] Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity
    Hyrich, Kimme L.
    Deighton, Chris
    Watson, Kath D.
    Symmons, Deborah P. M.
    Lunt, Mark
    RHEUMATOLOGY, 2009, 48 (10) : 1323 - 1327
  • [36] Influence of anti-TNF alpha therapy on lipid profile in rheumatoid arthritis patients
    Bernardes, M.
    Martins, E.
    Bernardo, A.
    Cardoso, L.
    Simoes-Ventura, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 176 - 177
  • [37] PATIENT EXPERIENCE WITH SUBCUTANEOUS ANTI-TNF THERAPY AMONG RHEUMATOID ARTHRITIS PATIENTS
    Tandon, N.
    Bolge, S.
    Annunziata, K.
    VALUE IN HEALTH, 2011, 14 (03) : A134 - A134
  • [38] Patients' perceptions of treatment with anti-TNF therapy for rheumatoid arthritis: a qualitative study
    Marshall, NJ
    Wilson, G
    Lapworth, K
    Kay, LJ
    RHEUMATOLOGY, 2004, 43 (08) : 1034 - 1038
  • [39] Infections in Patients With Rheumatoid Arthritis Undergoing Anti-TNF alpha Drug Therapy
    Alonso Ruiz, Alberto
    REUMATOLOGIA CLINICA, 2008, 4 : 18 - 23
  • [40] Anti-TNF therapy attrition rates and reasons for stopping in rheumatoid arthritis patients
    Pocock, J. M.
    Oestoer, A. J.
    RHEUMATOLOGY, 2008, 47 : II42 - II42
12345